The flu vaccine of the Moderna is the positive trial results, the pavement for the Combo Shot

Modern He said he had a Monday experience MRNA Based Infli Vaccination In a late-staged test, the product and the company produced a strong immune response than a phased trial, cleaning a way forward for a separate flu and a separate combination flu.

Moderna in May voluntarily withdrawn an app Covid-19 and the assertion of the targeting combination of influenza, this independently said he planned to result in a single flu vaccine, with effectiveness information in three trials. This decision, Secretary of Health and Human Services Robert F. Kennedy Jr, the famous vaccine skeptic, Secretary of Human Services Robert F. Kennedy Jr.

With new information, the company later plans to re-send the application for the vaccine and file confirmation of the short flu and the file.

When regulators approve the flu vaccine, the company can then develop a combination shot. He added that the modernine is waiting for reviews that will approve for both shots next year.

Moderna shares reached about 3% on Monday’s press trade.

Hoge, combination jab, doctors and nurses reduce workloads, reduce costs and reducing workloads between patients, “he said,” he said, “he said,” he said.

The company seems to be the front starting in the race so far Pfizer and Novavax to bring a combination stroke to the market. Although there is no special income forecasts for the individual products of Moderna, Hoge, Covid, flu and respiratory viral are every multibylion-dollar markets.

“It is clear that we allow our products to win our fair share of them,” he said.

The Phase Three Court followed MRNA-1010, a dose of MRNA-1010, a dose of a dose called a dose of a dose called a dose of a dose called a dose of a dose called a dose of a dose called a dose of more than 40,000 adults. The stroke of the moderna was 26.6% more effective in general work population.

MRNA-1010 CAB, A / H1N1, A / H3N2 and B / Victoria Lineages also demonstrated a strong effectiveness for each of the great flu strains in the shot. Moderna said the benefits of vaccine are consistent among people with various age groups, various risk factors and the status of the influenza.

In adults aged 65, the stroke was 27.4% more effective than the standard flu vaccine.

Efficiency results “” An important stage in our efforts to reduce the burden of the flu load in the elderly, “he said. “The severity of this former flu season emphasizes the need for more effective vaccination.”

Modern quoted information Disease control and prevention centers, seasonal flu-related hospitals and outpatient visits show that the visits reached 15 years in the 2024-2025 season. More than 600,000 Americans According to CDC, it was hospitalized last year due to influenza diseases.

The security information of the MRNA-1010 vaccine was in accordance with the previous results of the other three-one stages in the shot.

MODERNA shares were more than 30% for the year entering Monday, in a large part of the Trump management to change the policy of vaccine and disrupt the immunizations. Leadership in May canceled For humans, the bird flu was awarded for the late stage development of the vaccine.

Asked about an uncertain regulatory environment in the United States, Hoge, Moderna’nın said that the requirements of Moderna are closely attracted to FDA to understand how they will ensure.

“I believe that as it is in the flu, I think there is a very clear way,” he said.